DECISION OF THE EEA JOINT COMMITTEE No 232/2023

of 22 September 2023

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/985]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Regulation (EU) 2023/699 of 29 March 2023 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate with effect from 1 April 2023 ( 1 ) is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 15h (Council Regulation (EC) No 297/95) of Chapter XIII of Annex II to the EEA Agreement:

‘—

32023 R 0699 : Commission Regulation (EU) 2023/699 of 29 March 2023 ( OJ L 92, 30.3.2023, p. 1 ).’

Article 2

The text of Regulation (EU) 2023/699 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 23 September 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 22 September 2023.

For the EEA Joint Committee

The President

Pascal SCHAFHAUSER

( 1 ) OJ L 92, 30.3.2023, p. 1 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/985/oj

ISSN 1977-0677 (electronic edition)